We are live on ! Find out more
AMPH icon

Amphastar Pharmaceuticals
AMPH

136 hedge funds and large institutions have $489M invested in Amphastar Pharmaceuticals in 2020 Q3 according to their latest regulatory filings, with 17 funds opening new positions, 55 increasing their positions, 38 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

45% more repeat investments, than reductions

Existing positions increased: 55 | Existing positions reduced: 38

13% more first-time investments, than exits

New positions opened: 17 | Existing positions closed: 15

1% more funds holding

Funds holding: 135 → 136 (+1)

1.88% less ownership

Funds ownership: 57.01% → 55.13% (-1.9%)

17% less capital invested

Capital invested by funds: $591M → $489M (-$102M)

82% less call options, than puts

Call options by funds: $203K | Put options by funds: $1.11M

Holders
136
Holders Change
+1
Holders Change %
+0.74%
% of All Funds
2.74%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
17
Increased
55
Reduced
38
Closed
15
Calls
$203K
Puts
$1.11M
Net Calls
-$903K
Net Calls Change
+$1.46M

Top Buyers

1
BlackRock
BlackRock
New York
+$5.87M
2
Two Sigma Advisers
Two Sigma Advisers
New York
+$3.16M
3
Federated Hermes
Federated Hermes
Pennsylvania
+$2.82M
4
Two Sigma Investments
Two Sigma Investments
New York
+$2.73M
5
Goldman Sachs
Goldman Sachs
New York
+$2.1M

Top Sellers

1
VOYA Investment Management
VOYA Investment Management
Georgia
-$8.38M
2
Nordea Investment Management
Nordea Investment Management
Sweden
-$5.28M
3
Marshall Wace
Marshall Wace
United Kingdom
-$2.97M
4
Renaissance Technologies
Renaissance Technologies
New York
-$2.68M
5
Bessemer Group
Bessemer Group
New Jersey
-$2.51M
Name Holding Trade Value Shares
Change 		Change in
Stake
Millennium Management
126
Millennium Management
New York
$2.39K +$1.68M +83,631 +191%
ABC
127
Associated Banc-Corp
Wisconsin
$2K – – –
TFO
128
Tarbox Family Office
California
$2K – – –
GT
129
Glenmede Trust
Pennsylvania
$1K -$1.97K -98 -49%
LC
130
Lindbrook Capital
California
$1K – – –
QCG
131
Quadrant Capital Group
Ohio
$1K – – –
PFBT
132
Parkside Financial Bank & Trust
Missouri
$1K +$262 +13 +59%
ASN
133
Advisory Services Network
Georgia
$1K +$846 +42 New
Fidelity Investments
134
Fidelity Investments
Massachusetts
$1K +$1.01K +50 New
ACM
135
AUA Capital Management
Pennsylvania
$1K +$1.29K +64 New
Marshall Wace
136
Marshall Wace
United Kingdom
– -$2.97M -132,228 Closed
Bessemer Group
137
Bessemer Group
New Jersey
– -$2.51M -111,600 Closed
CSS
138
Cubist Systematic Strategies
Connecticut
– -$921K -41,009 Closed
TI
139
Trexquant Investment
Connecticut
– -$539K -23,980 Closed
QSS
140
Quantitative Systematic Strategies
Florida
– -$403K -17,933 Closed
Janney Montgomery Scott
141
Janney Montgomery Scott
Pennsylvania
– -$383K -17,038 Closed
CI
142
Cigna Investments
Connecticut
– -$337K -15,007 Closed
TCM
143
Teza Capital Management
Illinois
– -$298K -13,252 Closed
ECM
144
ExodusPoint Capital Management
New York
– -$286K -12,732 Closed
DCM
145
Dupont Capital Management
Delaware
– -$270K -12,040 Closed
HF
146
HRT Financial
New York
– -$261K -11,654 Closed
CAN
147
Cetera Advisor Networks
California
– -$90K -4,000 Closed
LIA
148
LS Investment Advisors
Michigan
– -$25K -1,108 Closed
PAG
149
Private Advisor Group
New Jersey
– -$8K -354 Closed
OPS
150
Orion Portfolio Solutions
Nebraska
– -$3K -113 Closed
2 3 4 5
6

AMPH Hedge Fund Activity: Q3 2020 in Review

136 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in Amphastar Pharmaceuticals (AMPH) for Q3 2020, worth a combined $489M — down 17% from $591M a quarter earlier.

Buyers outnumbered sellers: 17 funds opened new AMPH positions and 15 closed out — a net gain of 2 holders — while 55 added to existing stakes and 38 trimmed.

The largest buyer was BlackRock, adding an estimated $5.87M. The largest seller was VOYA Investment Management, cutting an estimated $8.38M.

  • 136 institutional investors held Amphastar Pharmaceuticals (AMPH) as of Q3 2020, up from 135 in Q2 2020.
  • Funds reported $489M of Amphastar Pharmaceuticals stock for Q3 2020, down 17% quarter-over-quarter.
  • 17 funds opened new Amphastar Pharmaceuticals positions in Q3 2020 and 15 closed out, a net change of +2 holders.
  • The largest Amphastar Pharmaceuticals buyer in Q3 2020 was BlackRock, an estimated $5.87M added.
  • The largest Amphastar Pharmaceuticals seller in Q3 2020 was VOYA Investment Management, an estimated $8.38M sold.

Based on aggregated 13F filings for Q3 2020.